Literature DB >> 21330666

Functional characterization of bestrophin-1 missense mutations associated with autosomal recessive bestrophinopathy.

Alice E Davidson1, Ian D Millar, Rosemary Burgess-Mullan, Geoffrey J Maher, Jill E Urquhart, Peter D Brown, Graeme C M Black, Forbes D C Manson.   

Abstract

PURPOSE: Autosomal recessive bestrophinopathy (ARB) is a retinal dystrophy affecting macular and retinal pigmented epithelium function resulting from homozygous or compound heterozygous mutations in BEST1. In this study we characterize the functional implications of missense bestrophin-1 mutations that cause ARB by investigating their effect on bestrophin-1's chloride conductance, cellular localization, and stability.
METHODS: The chloride conductance of wild-type bestropin-1 and a series of ARB mutants were determined by whole-cell patch-clamping of transiently transfected HEK cells. The effect of ARB mutations on the cellular localization of bestrophin-1 was determined by confocal immunofluorescence on transiently transfected MDCK II cells that had been polarized on Transwell filters. Protein stability of wild-type and ARB mutant forms of bestrophin-l was determined by the addition of proteasomal or lysosomal inhibitors to transiently transfected MDCK II cells. Lysates were then analyzed by Western blot analysis.
RESULTS: All ARB mutants investigated produced significantly smaller chloride currents compared to wild-type bestrophin-1. Additionally, co-transfection of compound heterozygous mutants abolished chloride conductance in contrast to co-transfections of a single mutant with wild-type bestrophin-l, reflecting the recessive nature of the condition. In control experiments, expression of two dominant vitelliform macular dystrophy mutants was shown to inhibit wild-type currents. Cellular localization of ARB mutants demonstrated that the majority did not traffic correctly to the plasma membrane and that five of these seven mutants were rapidly degraded by the proteasome. Two ARB-associated mutants (p.D312N and p.V317M) that were not trafficked correctly nor targeted to the proteasome had a distinctive appearance, possibly indicative of aggresome or aggresome-like inclusion bodies.
CONCLUSIONS: Differences in cellular processing mechanisms for different ARB associated mutants lead to the same disease phenotype. The existence of distinct pathogenic disease mechanisms has important ramifications for potential gene replacement therapies since we show that missense mutations associated with an autosomal recessive disease have a pathogenic influence beyond simple loss of function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330666     DOI: 10.1167/iovs.10-6707

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

Review 1.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

2.  A novel compound heterozygous mutation in the BEST1 gene causes autosomal recessive Best vitelliform macular dystrophy.

Authors:  L Zhao; S Grob; R Corey; M Krupa; J Luo; H Du; C Lee; G Hughes; J Lee; J Quach; J Zhu; P X Shaw; I Kozak; K Zhang
Journal:  Eye (Lond)       Date:  2012-03-16       Impact factor: 3.775

3.  Light-responsive microRNA miR-211 targets Ezrin to modulate lysosomal biogenesis and retinal cell clearance.

Authors:  Federica Naso; Daniela Intartaglia; Danila Falanga; Chiara Soldati; Elena Polishchuk; Giuliana Giamundo; Paola Tiberi; Elena Marrocco; Paolo Scudieri; Chiara Di Malta; Ivana Trapani; Edoardo Nusco; Francesco Giuseppe Salierno; Enrico Maria Surace; Luis Jv Galietta; Sandro Banfi; Alberto Auricchio; Andrea Ballabio; Diego Luis Medina; Ivan Conte
Journal:  EMBO J       Date:  2020-03-10       Impact factor: 11.598

4.  Pathogenicity of new BEST1 variants identified in Italian patients with best vitelliform macular dystrophy assessed by computational structural biology.

Authors:  Vladimir Frecer; Giancarlo Iarossi; Anna Paola Salvetti; Paolo Enrico Maltese; Giulia Delledonne; Marta Oldani; Giovanni Staurenghi; Benedetto Falsini; Angelo Maria Minnella; Lucia Ziccardi; Adriano Magli; Leonardo Colombo; Fabiana D'Esposito; Jan Miertus; Francesco Viola; Marcella Attanasio; Emilia Maggio; Matteo Bertelli
Journal:  J Transl Med       Date:  2019-10-01       Impact factor: 5.531

5.  Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking.

Authors:  Adiv A Johnson; Yong-Suk Lee; J Brett Stanton; Kuai Yu; Criss H Hartzell; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2013-07-03       Impact factor: 6.150

6.  Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation.

Authors:  Adiv A Johnson; Lori A Bachman; Benjamin J Gilles; Samuel D Cross; Kimberly E Stelzig; Zachary T Resch; Lihua Y Marmorstein; Jose S Pulido; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

7.  Noncanonical autophagy promotes the visual cycle.

Authors:  Ji-Young Kim; Hui Zhao; Jennifer Martinez; Teresa Ann Doggett; Alexander V Kolesnikov; Peter H Tang; Zsolt Ablonczy; Chi-Chao Chan; Zhenqing Zhou; Douglas R Green; Thomas A Ferguson
Journal:  Cell       Date:  2013-07-18       Impact factor: 41.582

8.  Effects of alternative splicing on the function of bestrophin-1 calcium-activated chloride channels.

Authors:  Yu-Hung Kuo; Iskandar F Abdullaev; María C Hyzinski-García; Alexander A Mongin
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

9.  Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.

Authors:  Adiv A Johnson; Yong-Suk Lee; Andrew J Chadburn; Paolo Tammaro; Forbes D Manson; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Exp Eye Res       Date:  2014-02-19       Impact factor: 3.467

10.  RUBCN/rubicon and EGFR regulate lysosomal degradative processes in the retinal pigment epithelium (RPE) of the eye.

Authors:  Luis Muniz-Feliciano; Teresa A Doggett; Zhenqing Zhou; Thomas A Ferguson
Journal:  Autophagy       Date:  2017       Impact factor: 13.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.